questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Récepteurs de surface cellulaire
Récepteurs immunologiques
Intégrines
Intégrines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Protein Processing, Post-Translational
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Intégrines : Questions médicales les plus fréquentes",
"headline": "Intégrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Intégrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-09",
"dateModified": "2025-02-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Intégrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Récepteurs immunologiques",
"url": "https://questionsmedicales.fr/mesh/D011971",
"about": {
"@type": "MedicalCondition",
"name": "Récepteurs immunologiques",
"code": {
"@type": "MedicalCode",
"code": "D011971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Intégrines alpha",
"alternateName": "Integrin alpha Chains",
"url": "https://questionsmedicales.fr/mesh/D039001",
"about": {
"@type": "MedicalCondition",
"name": "Intégrines alpha",
"code": {
"@type": "MedicalCode",
"code": "D039001",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha1",
"alternateName": "Integrin alpha1",
"url": "https://questionsmedicales.fr/mesh/D039423",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha1",
"code": {
"@type": "MedicalCode",
"code": "D039423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha2",
"alternateName": "Integrin alpha2",
"url": "https://questionsmedicales.fr/mesh/D039421",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha2",
"code": {
"@type": "MedicalCode",
"code": "D039421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha3",
"alternateName": "Integrin alpha3",
"url": "https://questionsmedicales.fr/mesh/D039422",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha3",
"code": {
"@type": "MedicalCode",
"code": "D039422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha4",
"alternateName": "Integrin alpha4",
"url": "https://questionsmedicales.fr/mesh/D039441",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha4",
"code": {
"@type": "MedicalCode",
"code": "D039441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha5",
"alternateName": "Integrin alpha5",
"url": "https://questionsmedicales.fr/mesh/D039482",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha5",
"code": {
"@type": "MedicalCode",
"code": "D039482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alpha6",
"alternateName": "Integrin alpha6",
"url": "https://questionsmedicales.fr/mesh/D039503",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alpha6",
"code": {
"@type": "MedicalCode",
"code": "D039503",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine alphaV",
"alternateName": "Integrin alphaV",
"url": "https://questionsmedicales.fr/mesh/D039564",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine alphaV",
"code": {
"@type": "MedicalCode",
"code": "D039564",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.900"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glycoprotéine-IIb de membrane plaquettaire",
"alternateName": "Platelet Membrane Glycoprotein IIb",
"url": "https://questionsmedicales.fr/mesh/D040201",
"about": {
"@type": "MedicalCondition",
"name": "Glycoprotéine-IIb de membrane plaquettaire",
"code": {
"@type": "MedicalCode",
"code": "D040201",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.100.950"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chaines bêta des intégrines",
"alternateName": "Integrin beta Chains",
"url": "https://questionsmedicales.fr/mesh/D039641",
"about": {
"@type": "MedicalCondition",
"name": "Chaines bêta des intégrines",
"code": {
"@type": "MedicalCode",
"code": "D039641",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes CD29",
"alternateName": "Integrin beta1",
"url": "https://questionsmedicales.fr/mesh/D019012",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes CD29",
"code": {
"@type": "MedicalCode",
"code": "D019012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine bêta3",
"alternateName": "Integrin beta3",
"url": "https://questionsmedicales.fr/mesh/D039661",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine bêta3",
"code": {
"@type": "MedicalCode",
"code": "D039661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.200.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Intégrine bêta4",
"alternateName": "Integrin beta4",
"url": "https://questionsmedicales.fr/mesh/D039663",
"about": {
"@type": "MedicalCondition",
"name": "Intégrine bêta4",
"code": {
"@type": "MedicalCode",
"code": "D039663",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.200.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Récepteur cytoadhésine",
"alternateName": "Receptors, Cytoadhesin",
"url": "https://questionsmedicales.fr/mesh/D016024",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur cytoadhésine",
"code": {
"@type": "MedicalCode",
"code": "D016024",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.460"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Récepteur vitronectine",
"alternateName": "Receptors, Vitronectin",
"url": "https://questionsmedicales.fr/mesh/D019030",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur vitronectine",
"code": {
"@type": "MedicalCode",
"code": "D019030",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.460.870"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Récepteur du fibrinogène",
"alternateName": "Receptors, Fibrinogen",
"url": "https://questionsmedicales.fr/mesh/D039341",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur du fibrinogène",
"code": {
"@type": "MedicalCode",
"code": "D039341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.495"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur fibronectine",
"alternateName": "Receptors, Fibronectin",
"url": "https://questionsmedicales.fr/mesh/D017469",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur fibronectine",
"code": {
"@type": "MedicalCode",
"code": "D017469",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.530"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur adhésion leucocytaire",
"alternateName": "Receptors, Leukocyte-Adhesion",
"url": "https://questionsmedicales.fr/mesh/D016028",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur adhésion leucocytaire",
"code": {
"@type": "MedicalCode",
"code": "D016028",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récepteur VLA",
"alternateName": "Receptors, Very Late Antigen",
"url": "https://questionsmedicales.fr/mesh/D016029",
"about": {
"@type": "MedicalCondition",
"name": "Récepteur VLA",
"code": {
"@type": "MedicalCode",
"code": "D016029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.750.705.408.850"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Intégrines",
"alternateName": "Integrins",
"code": {
"@type": "MedicalCode",
"code": "D016023",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Johanna Ivaska",
"url": "https://questionsmedicales.fr/author/Johanna%20Ivaska",
"affiliation": {
"@type": "Organization",
"name": "Turku Bioscience Center, University of Turku and Åbo Akademi University, FIN-20520 Turku, Finland; Department of Biochemistry, University of Turku, FIN-20520 Turku, Finland. Electronic address: joivaska@utu.fi."
}
},
{
"@type": "Person",
"name": "Jia Liu",
"url": "https://questionsmedicales.fr/author/Jia%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Shenzhen Jiake Biotechnology, Shenzhen, China."
}
},
{
"@type": "Person",
"name": "Michael Bachmann",
"url": "https://questionsmedicales.fr/author/Michael%20Bachmann",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland."
}
},
{
"@type": "Person",
"name": "Vesa P Hytönen",
"url": "https://questionsmedicales.fr/author/Vesa%20P%20Hyt%C3%B6nen",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland."
}
},
{
"@type": "Person",
"name": "Bernhard Wehrle-Haller",
"url": "https://questionsmedicales.fr/author/Bernhard%20Wehrle-Haller",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland bernhard.wehrle-haller@unige.ch."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillance.",
"datePublished": "2023-10-31",
"url": "https://questionsmedicales.fr/article/38020164",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fmed.2023.1264846"
}
},
{
"@type": "ScholarlyArticle",
"name": "Post-mortem radiology in fetal and neonatal death: the diagnostic value of post-mortem MRI versus autopsy regarding non-cardiac thoracic and abdominal abnormalities.",
"datePublished": "2023-08-12",
"url": "https://questionsmedicales.fr/article/37633747",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.crad.2023.07.021"
}
},
{
"@type": "ScholarlyArticle",
"name": "Post-sign-off events in infectious disease consultation and the incidence of nonadherence to infectious disease recommendations in the post-sign-off period: A retrospective cohort study.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36960090",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/ash.2023.121"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protein-protein interaction network study of metallo-beta-lactamase-L1 present in",
"datePublished": "2024-10-29",
"url": "https://questionsmedicales.fr/article/39479381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40203-024-00270-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Studies of Protein Phase Separation Using Leishmania Kinetoplastid Membrane Protein-11.",
"datePublished": "2024-10-23",
"url": "https://questionsmedicales.fr/article/39439298",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jpcb.4c04373"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Récepteurs de surface cellulaire",
"item": "https://questionsmedicales.fr/mesh/D011956"
},
{
"@type": "ListItem",
"position": 6,
"name": "Récepteurs immunologiques",
"item": "https://questionsmedicales.fr/mesh/D011971"
},
{
"@type": "ListItem",
"position": 7,
"name": "Intégrines",
"item": "https://questionsmedicales.fr/mesh/D016023"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Intégrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Intégrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Intégrines",
"description": "Comment diagnostiquer une dysfonction des intégrines ?\nQuels examens sont utilisés pour évaluer les intégrines ?\nLes biopsies sont-elles utiles pour les intégrines ?\nPeut-on détecter les intégrines par imagerie ?\nQuels marqueurs sont associés aux intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Protein+Processing,+Post-Translational&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Intégrines",
"description": "Quels symptômes indiquent une anomalie des intégrines ?\nLes troubles de la coagulation sont-ils liés aux intégrines ?\nComment les intégrines affectent-elles la cicatrisation ?\nLes douleurs articulaires peuvent-elles être liées aux intégrines ?\nY a-t-il des symptômes cutanés associés aux intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Protein+Processing,+Post-Translational&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Intégrines",
"description": "Peut-on prévenir les troubles liés aux intégrines ?\nLes vaccinations influencent-elles les intégrines ?\nL'exercice physique affecte-t-il les intégrines ?\nLe stress a-t-il un impact sur les intégrines ?\nLes habitudes alimentaires influencent-elles les intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Protein+Processing,+Post-Translational&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Intégrines",
"description": "Quels traitements ciblent les intégrines ?\nLes médicaments anti-inflammatoires aident-ils les intégrines ?\nLa thérapie génique peut-elle corriger les anomalies des intégrines ?\nLes greffes d'organes sont-elles affectées par les intégrines ?\nComment les intégrines sont-elles ciblées dans le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Protein+Processing,+Post-Translational&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Intégrines",
"description": "Quelles complications peuvent survenir avec des anomalies des intégrines ?\nLes anomalies des intégrines peuvent-elles causer des cancers ?\nComment les intégrines affectent-elles la santé cardiovasculaire ?\nLes complications cutanées sont-elles fréquentes avec les intégrines ?\nLes troubles neurologiques peuvent-ils être liés aux intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Protein+Processing,+Post-Translational&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Intégrines",
"description": "Quels facteurs augmentent le risque de troubles des intégrines ?\nL'âge influence-t-il la fonction des intégrines ?\nLe tabagisme affecte-t-il les intégrines ?\nLe diabète influence-t-il les intégrines ?\nLe stress oxydatif affecte-t-il les intégrines ?",
"url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Protein+Processing,+Post-Translational&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des intégrines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de sang peuvent aider à diagnostiquer les anomalies des intégrines."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les intégrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunofluorescence et la cytométrie en flux sont couramment utilisés pour évaluer les intégrines."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour les intégrines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent révéler des anomalies d'expression des intégrines dans les tissus."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les intégrines par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines techniques d'imagerie moléculaire peuvent visualiser l'expression des intégrines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux intégrines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme CD29 et CD49 peuvent être utilisés pour identifier les intégrines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des intégrines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes d'adhésion cellulaire peuvent entraîner des inflammations et des infections récurrentes."
}
},
{
"@type": "Question",
"name": "Les troubles de la coagulation sont-ils liés aux intégrines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies des intégrines peuvent provoquer des troubles de la coagulation sanguine."
}
},
{
"@type": "Question",
"name": "Comment les intégrines affectent-elles la cicatrisation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les intégrines sont essentielles pour la migration cellulaire et la formation de nouveaux tissus lors de la cicatrisation."
}
},
{
"@type": "Question",
"name": "Les douleurs articulaires peuvent-elles être liées aux intégrines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements des intégrines peuvent contribuer à des douleurs articulaires et à l'arthrite."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux intégrines ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies des intégrines peuvent entraîner des maladies cutanées comme l'épidermolyse bulleuse."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux intégrines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles liés aux intégrines."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les intégrines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent moduler l'expression des intégrines, influençant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique affecte-t-il les intégrines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la fonction des intégrines et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les intégrines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut altérer l'expression des intégrines, affectant la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les intégrines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut soutenir la fonction des intégrines et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les intégrines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques, comme les inhibiteurs d'intégrines, sont utilisées pour traiter certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les médicaments anti-inflammatoires aident-ils les intégrines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anti-inflammatoires peuvent réduire l'inflammation liée aux dysfonctionnements des intégrines."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle corriger les anomalies des intégrines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est une approche prometteuse pour corriger certaines anomalies des intégrines."
}
},
{
"@type": "Question",
"name": "Les greffes d'organes sont-elles affectées par les intégrines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les intégrines jouent un rôle clé dans l'acceptation ou le rejet des greffes d'organes."
}
},
{
"@type": "Question",
"name": "Comment les intégrines sont-elles ciblées dans le cancer ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblant les intégrines peuvent inhiber la métastase et la progression tumorale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies des intégrines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections récurrentes, des troubles de la coagulation et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les anomalies des intégrines peuvent-elles causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans l'expression des intégrines sont associées à une augmentation du risque de cancer."
}
},
{
"@type": "Question",
"name": "Comment les intégrines affectent-elles la santé cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dysfonctionnements des intégrines peuvent contribuer à des maladies cardiovasculaires et à l'athérosclérose."
}
},
{
"@type": "Question",
"name": "Les complications cutanées sont-elles fréquentes avec les intégrines ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies des intégrines peuvent entraîner des maladies cutanées graves comme l'épidermolyse."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques peuvent-ils être liés aux intégrines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les anomalies des intégrines et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles des intégrines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, des infections chroniques et des maladies auto-immunes augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la fonction des intégrines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut altérer l'expression et la fonction des intégrines dans le corps."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il les intégrines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut perturber l'expression des intégrines et affecter la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Le diabète influence-t-il les intégrines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut altérer la fonction des intégrines, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif affecte-t-il les intégrines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut endommager les intégrines et perturber leur fonction normale."
}
}
]
}
]
}
Deep Ensemble for Recognition of Malignancy (DERM) is an artificial intelligence as a medical device (AIaMD) tool for skin lesion assessment....
We report prospective real-world performance from its deployment within skin cancer pathways at two National Health Service hospitals (UK) between July 2021 and October 2022....
A total of 14,500 cases were seen, including patients 18-100 years old with Fitzpatrick skin types I-VI represented. Based on 8,571 lesions assessed by DERM with confirmed outcomes, versions A and B d...
We show DERM performance in-line with sensitivity targets and pre-marketing authorisation research, and it reduced the caseload for hospital specialists in two pathways. Based on our experience we off...
To compare the diagnostic value and accuracy of post-mortem magnetic resonance imaging (PMMRI) and autopsy for non-cardiac thoracic and abdominal abnormalities in fetal death....
This single-institution retrospective study included all consecutive cases of fetal and perinatal death between January 2015 and December 2021 for which PMMRI followed by autopsy was conducted. These ...
Eighty cases were included in this study. Fetal loss was caused by termination of pregnancy in 80% of cases. Further, the mean gestational age was 166 days (23 weeks and 5 days, range 126-283 days). T...
PMMRI exhibited good overall diagnostic value for non-cardiac thoracic and abdominal abnormalities, specifically large structural abnormalities. PMMRI may offer parents and physicians a valuable addit...
Infectious diseases (ID) consultation has contributed to improving outcomes in hospitalized patients. However, the timing of signing off on ID consultation varies, depending on the consulting ID physi...
This retrospective cohort study was conducted at a Japanese tertiary-care center. All patients who received ID consultation between January and December 2019 and treatment recommendations for a confir...
In total, 367 patients receiving ID consultation were included. The incidence of post-sign-off events during index hospitalization was 59 (16.1%) of 367, with antimicrobial-associated ADEs accounting ...
Post-sign-off events were common and led to nonadherence to ID recommendations during the post-sign-off period. Because this nonadherence occurs for various reasons, patients may require continued att...
Microorganisms are evolving to withstand the effect of antimicrobial agents and thereby pose a global threat known as antimicrobial resistance. Resistance towards multiple drugs due to various intrins...
The online version contains supplementary material available at 10.1007/s40203-024-00270-9....
Despite the significant understanding of phase separation in proteins with intrinsically disordered regions, a considerable percentage of proteins without such regions also undergo phase separation, p...
Whey protein concentrate (WPC) is consumed for its high protein content. The structure and biological functionality of whey proteins in WPC powders may be affected by the drying technique applied. How...
The respiratory syncytial virus (RSV) matrix (M) protein plays an important role in infection as it can interact with viral components as well as the host cell actin microfilaments. The M-actin intera...
Esophageal squamous cell carcinoma (ESCC) is a prevalent malignant tumor of the digestive tract. Clinical findings reveal that the five-year survival rate for mid-to late-stage ESCC patients is merely...
A major challenge in computer-aided drug design is predicting relative binding energies of different molecules to a target protein using fast and accurate free-energy calculation methods. Free-energy ...
Protein-protein interactions (PPIs) are central to the cellular signaling and regulatory networks that underlie many physiological and pathophysiological processes. It is challenging to target PPIs us...